A
Anne-Michelle Noone
Researcher at Georgetown University
Publications - 40
Citations - 9946
Anne-Michelle Noone is an academic researcher from Georgetown University. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 25, co-authored 39 publications receiving 8665 citations. Previous affiliations of Anne-Michelle Noone include Georgetown University Medical Center & University of North Carolina at Chapel Hill.
Papers
More filters
Journal ArticleDOI
Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.
A. Blythe Ryerson,Christie R. Eheman,Sean F. Altekruse,John W. Ward,Ahmedin Jemal,Recinda L. Sherman,S. Jane Henley,Deborah Holtzman,Andrew C Lake,Anne-Michelle Noone,Robert N. Anderson,Jiemin Ma,Kathleen N. Ly,Kathleen A. Cronin,Lynne Penberthy,Betsy A. Kohler +15 more
TL;DR: The increasing burden of liver and intrahepatic bile duct (liver) cancers is highlighted in this annual report.
Journal ArticleDOI
Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity.
Christie R. Eheman,S. Jane Henley,Rachel Ballard-Barbash,Eric J. Jacobs,Maria J. Schymura,Anne-Michelle Noone,Liping Pan,Robert N. Anderson,Janet E. Fulton,Betsy A. Kohler,Ahmedin Jemal,Elizabeth Ward,Marcus Plescia,Lynn A. G. Ries,Brenda K. Edwards +14 more
TL;DR: This year's report highlights the increased cancer risk associated with excess weight (overweight or obesity) and lack of sufficient physical activity (150 minutes of physical activity per week).
Journal ArticleDOI
Comparison of SEER Treatment Data With Medicare Claims
Anne-Michelle Noone,Jennifer L. Lund,Angela B. Mariotto,Kathleen A. Cronin,Timothy S. McNeel,Dennis Deapen,Joan L. Warren +6 more
TL;DR: SEER data should not generally be used for comparisons of treated and untreated individuals or to estimate the proportion of treated individuals in the population, andAugmenting SEER data with other data sources will provide the most accurate treatment information.
Journal ArticleDOI
Circulating Tumor Cells: A Useful Predictor of Treatment Efficacy in Metastatic Breast Cancer
Minetta C. Liu,Peter G. Shields,Robert D. Warren,Philip Cohen,Mary Wilkinson,Yvonne L. Ottaviano,Suman B. Rao,Jennifer Eng-Wong,Françoise Seillier-Moiseiwitsch,Anne-Michelle Noone,Claudine Isaacs +10 more
TL;DR: The first evidence of a strong correlation between CTC results and radiographic disease progression in patients receiving chemotherapy or endocrine therapy for MBC is provided and support the role of CTC enumeration as an adjunct to standard methods of monitoring disease status in MBC.
Journal ArticleDOI
Cancer Incidence and Survival Trends by Subtype Using Data from the Surveillance Epidemiology and End Results Program, 1992–2013
Anne-Michelle Noone,Kathleen A. Cronin,Sean F. Altekruse,Nadia Howlader,Denise Riedel Lewis,Valentina I. Petkov,Lynne Penberthy +6 more
TL;DR: Presenting incidence and survival trends by subtype, whenever possible, is critical to provide more detailed and meaningful data to patients, providers, and the public.